KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Short term Debt (2016 - 2025)

Ionis Pharmaceuticals has reported Short term Debt over the past 17 years, most recently at $431.9 million for Q4 2025.

  • Quarterly results put Short term Debt at $431.9 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $431.9 million (changed N/A YoY), and the annual figure for FY2025 was $431.9 million, changed.
  • Short term Debt for Q4 2025 was $431.9 million at Ionis Pharmaceuticals, down from $630.9 million in the prior quarter.
  • Over the last five years, Short term Debt for IONS hit a ceiling of $630.9 million in Q3 2025 and a floor of $3.1 million in Q3 2021.
  • Median Short term Debt over the past 5 years was $44.4 million (2023), compared with a mean of $140.1 million.
  • Biggest five-year swings in Short term Debt: surged 1389.54% in 2021 and later crashed 93.2% in 2022.
  • Ionis Pharmaceuticals' Short term Debt stood at $3.5 million in 2021, then surged by 40.95% to $5.0 million in 2022, then skyrocketed by 791.99% to $44.3 million in 2023, then increased by 0.3% to $44.5 million in 2024, then surged by 871.39% to $431.9 million in 2025.
  • The last three reported values for Short term Debt were $431.9 million (Q4 2025), $630.9 million (Q3 2025), and $630.1 million (Q2 2025) per Business Quant data.